|
|
|
|
|
Thymopentin |
|
C30H49N9O9 |
|
69558-55-0 |
|
It is clinically used for the chronic hepatitis B patients over 18 years old all kinds of primary or secondary T cell deficiency disease some autoimmune diseases all kinds of diseases with low cellular immunity and the assisted treatment of tumor. |
|
Parameters of Product: 1 .Appearance :White powder 2 .Specific Optical Rotation (c=2,H2O) :-16.0~-20.0¡Æ 3 .pH :7.0~9.0 4 .Water Content(K.F.) :¡Â5.0% 5 .Acetate Content(By HPLC) :¡Â0.2% 6 .Amino Acid Composition :¡¾10% of theoretical 7 .Purity(By HPLC) :¡Ã98.5% 8 .Single Impurity(By HPLC) :¡Â1.0% 9 .Assay(By Anhydrous) :¡Ã98.0% 10 .Bacterial Endotoxins :¡Â5EU/mg
|
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|